SpecGx, LLC recalls Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119,…

Recall date

December 16, 2025

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0255-2026

FDA classification

Class II

Brand / firm

SpecGx, LLC

Sold / distributed

Nationwide

Why it was recalled

Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0522-01. Case label: SpecGx LLC, NDC 0406052201, Exp. 2027/03, Lot: 0522J23493